Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Clinical trial NCT04906421 · COMPLETED

Trial details

NCT number: NCT04906421
Sponsor: Sagimet Biosciences Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease

Start date: 2021-08-12
Primary completion: 2023-10-02
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.